Home / Advanced Search

  • Title/Keywords

  • Author/Affliations

  • Journal

  • Article Type

  • Start Year

  • End Year

Update SearchingClear
  • Articles
  • Online
Search Results (1)
  • Open Access

    ARTICLE

    Leukemia Inhibitory Factor Promotes Aggressiveness of Chordoma

    Sukru Gulluoglu*†, Mesut Sahin, Emre Can Tuysuz, Cumhur Kaan Yaltirik§, Aysegul Kuskucu*, Ferda Ozkan, Fikrettin Sahin, Ugur Ture§, Omer Faruk Bayrak*

    Oncology Research, Vol.25, No.7, pp. 1177-1188, 2017, DOI:10.3727/096504017X14874349473815

    Abstract Chordomas are rare tumors of the spine and skull base that are locally destructive and resistant to chemotherapy and radiation therapy, with a poor prognosis and limited therapeutic options. Chordoma patients have a long life expectancy with high mortality from the disease. Cancer stem cells, which are known to exist in chordomas, have extensive proliferative and self-renewal potential and are responsible for maintaining tumor heterogeneity along with chemotherapy and radiotherapy resistance. Leukemia inhibitory factor (LIF) has multiple functions in stem cell biology, the immune response, and cancer, and is potentially a key molecule that allows… More >

Displaying 1-10 on page 1 of 1. Per Page